Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemfab Alkalis Ltd Capital/Financing Update 2021

Apr 9, 2021

62225_rns_2021-04-09_be60e0f5-27c4-44da-adc2-d2026ad3e2d1.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [452 x 103] intentionally omitted <==

REF: CHEMFAB/SEC/2020 - 21

April 9, 2021

The Manager, The Manager, The Bombay Stock Exchange Limited., National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Bandra (E) Mumbai- 400001 Mumbai – 400 051

BSE – Security Code: 541269 NSE Symbol: CHEMFAB

Dear Sir/ Madam,

Sub: Intimation under Regulation 30(4) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In pursuant to the provisions of Schedule III, Part – B, read with the regulation 30 (4) of SEBI (LODR) Regulations 2015, we wish to inform you that the Company has received Consent to Operate (CTO) enhancing our Caustic Soda capacity from 45600 TPA to 56575 TPA . Consent capacities of all co-products has also been enhanced.

All Capex were funded through internal accruals.

We request you to kindly take the same on record.

Yours’ Faithfully,

For CHEMFAB ALKALIS LIMITED

==> picture [113 x 53] intentionally omitted <==

==> picture [92 x 72] intentionally omitted <==

Dr. V. Rajesh Company Secretary

==> picture [468 x 59] intentionally omitted <==